Biosortia Pharmaceuticals, a Dublin-based subsidiary of Marysville-based Algaeventure Systems Inc. announced its CEO is Kurt Dieck Columbus, Ohio (January 28, 2013) – A startup prospecting mucky ponds for the pharmaceutical promise has hired two top executives with Fortune 100 experience. Biosortia Pharmaceuticals, a Dublin-based subsidiary of Marysville-based Algaeventure Systems Inc. announced its CEO is Kurt
Biosortia Pharmaceuticals Hires Kurt Dieck as President and CEO to Accelerate Strategy to Develop and License New Highly Active Compounds from Unculturable Aquatic Microbial Consortia Dublin, Ohio (January 22, 2013) – Kurt Dieck formerly SVP of Strategy and Business Execution at Cardinal Health, will lead the early-stage drug discovery business at Biosortia Pharmaceuticals. Dieck was named
